检索结果-南通市图书馆

Interventional Effect of Jianpi Bushen Granule Combined with Western Medicine on the Level of Serum Acetylcholine Receptor Antibodies in Myasthenia Gravis Patients

引用

World Journal of Traditional Chinese Medicine 2015年第4期1卷 42-47页

作者： Chao Jiang Ping Liu Jing-Sheng Zhang Wen-Jing Bao Yan Liang Shao-Bo Qiu Lin Jiang Department of Neurology Xijing Hospital the Fourth Military Medical University Traditional Chinese Medicine Department of Longhua Hospital Affiliated to Shanghai University of traditional Chinese Medicine Neurological Medical Department of the China Affiliated Hospital of Liaoning University of Traditional Chinese Medicine State Key Laboratory of Bioreactor Engineering & Shanghai Key Laboratory of New Drug Design School of Pharmacy East China University of Science and Technology

Objective: This study is aimed to investigate the clinical significance of regulating effect of Jianpi Bushen Granule(JBG) combined with Western medicine on the level of serum acetylcholine receptor antibodies(AchRAb) in myasthenia gravis(MG) patients, so as to offer a theoretical basis of the targeted therapy with ***: We detected the level of anti-AchRAb with enzyme linked immunosorbent assay(ELISA) in the sera from 60 cases of MG patients(randomly divided into the trial group 30 cases, control group 30) for before and after treatment 6 months, and the clinical evaluation carried out by the Quantitative score of myasthenia gravis(QMG) for before and after treatment 3,6 ***:(1) Comparison of the level of serum AchRAb:All included MG patients, the positive rate of serum AchRAb was about 81.67%(49/60),and the trial group was 83.33%(25/30),the control group was 90%(27/30).and the serum AchRAb levels of the trial group(0.994 ±0.417) was lower than that of the contral group(1.068 ± 0.358),but there was no significant difference between the two groups before treatment(P> 0.05). After 6 months of treatment, the serum AchRAb levels of the trial group(0.721 ± 0.280) was also significantly lower than that of the contral group(0.907 ± 0.387),and the serum AchRAb levels was decreased dramatically compared with the same group before treatment, there was significant difference between the two groups(P<0.05).(2)Comparison of QMG scoring:QMG scoring was decreased dramatically in the trial group compared with that of the control group after treatment, there was significant difference(P < 0.05), moreover,the total effective rate in the trial group(50%,86.67%)was significantly higher than those in the control groups(23.33%, 40%) after 3,6 months treatment(P < 0.05). There was also significant difference in the clinical evaluation by the QMG between the two groups before and after treatment.(3) Adverse reactions: no obvious adverse reactions appeared among the tw

关键词： Myasthenia gravis JBG AchRAb elisia

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

欢迎您,

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

请选择保存的检索档案：

请选择收藏分类：

通借通还

欢迎您,

建议与咨询 留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

请选择保存的检索档案： 新增检索档案 确定 取消

请选择收藏分类： 新增自定义分类 确定 取消

通借通还

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

请选择保存的检索档案：

请选择收藏分类：